Molecular Biomarkers-Global Market Status & Trend Report 2013-2023 Top 20 CountriesData
Report Summary
Molecular Biomarkers-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Molecular Biomarkers industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Molecular Biomarkers 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Molecular Biomarkers worldwide and market share by regions, with company and product introduction, position in the Molecular Biomarkers market
Market status and development trend of Molecular Biomarkers by types and applications
Cost and profit status of Molecular Biomarkers, and marketing status
Market growth drivers and challenges
The report segments the global Molecular Biomarkers market as:
Global Molecular Biomarkers Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Molecular Biomarkers Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Genomics
Proteomics
Others
Global Molecular Biomarkers Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medicine
Biology
Other
Global Molecular Biomarkers Market: Manufacturers Segment Analysis (Company and Product introduction, Molecular Biomarkers Sales Volume, Revenue, Price and Gross Margin):
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Molecular Biomarkers-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Molecular Biomarkers industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Molecular Biomarkers 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Molecular Biomarkers worldwide and market share by regions, with company and product introduction, position in the Molecular Biomarkers market
Market status and development trend of Molecular Biomarkers by types and applications
Cost and profit status of Molecular Biomarkers, and marketing status
Market growth drivers and challenges
The report segments the global Molecular Biomarkers market as:
Global Molecular Biomarkers Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Molecular Biomarkers Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Genomics
Proteomics
Others
Global Molecular Biomarkers Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medicine
Biology
Other
Global Molecular Biomarkers Market: Manufacturers Segment Analysis (Company and Product introduction, Molecular Biomarkers Sales Volume, Revenue, Price and Gross Margin):
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MOLECULAR BIOMARKERS
1.1 Definition of Molecular Biomarkers in This Report
1.2 Commercial Types of Molecular Biomarkers
1.2.1 Genomics
1.2.2 Proteomics
1.2.3 Others
1.3 Downstream Application of Molecular Biomarkers
1.3.1 Medicine
1.3.2 Biology
1.3.3 Other
1.4 Development History of Molecular Biomarkers
1.5 Market Status and Trend of Molecular Biomarkers 2013-2023
1.5.1 Global Molecular Biomarkers Market Status and Trend 2013-2023
1.5.2 Regional Molecular Biomarkers Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Molecular Biomarkers 2013-2017
2.2 Sales Market of Molecular Biomarkers by Regions
2.2.1 Sales Volume of Molecular Biomarkers by Regions
2.2.2 Sales Value of Molecular Biomarkers by Regions
2.3 Production Market of Molecular Biomarkers by Regions
2.4 Global Market Forecast of Molecular Biomarkers 2018-2023
2.4.1 Global Market Forecast of Molecular Biomarkers 2018-2023
2.4.2 Market Forecast of Molecular Biomarkers by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Molecular Biomarkers by Types
3.2 Sales Value of Molecular Biomarkers by Types
3.3 Market Forecast of Molecular Biomarkers by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Molecular Biomarkers by Downstream Industry
4.2 Global Market Forecast of Molecular Biomarkers by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Molecular Biomarkers Market Status by Countries
5.1.1 North America Molecular Biomarkers Sales by Countries (2013-2017)
5.1.2 North America Molecular Biomarkers Revenue by Countries (2013-2017)
5.1.3 United States Molecular Biomarkers Market Status (2013-2017)
5.1.4 Canada Molecular Biomarkers Market Status (2013-2017)
5.1.5 Mexico Molecular Biomarkers Market Status (2013-2017)
5.2 North America Molecular Biomarkers Market Status by Manufacturers
5.3 North America Molecular Biomarkers Market Status by Type (2013-2017)
5.3.1 North America Molecular Biomarkers Sales by Type (2013-2017)
5.3.2 North America Molecular Biomarkers Revenue by Type (2013-2017)
5.4 North America Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Molecular Biomarkers Market Status by Countries
6.1.1 Europe Molecular Biomarkers Sales by Countries (2013-2017)
6.1.2 Europe Molecular Biomarkers Revenue by Countries (2013-2017)
6.1.3 Germany Molecular Biomarkers Market Status (2013-2017)
6.1.4 UK Molecular Biomarkers Market Status (2013-2017)
6.1.5 France Molecular Biomarkers Market Status (2013-2017)
6.1.6 Italy Molecular Biomarkers Market Status (2013-2017)
6.1.7 Russia Molecular Biomarkers Market Status (2013-2017)
6.1.8 Spain Molecular Biomarkers Market Status (2013-2017)
6.1.9 Benelux Molecular Biomarkers Market Status (2013-2017)
6.2 Europe Molecular Biomarkers Market Status by Manufacturers
6.3 Europe Molecular Biomarkers Market Status by Type (2013-2017)
6.3.1 Europe Molecular Biomarkers Sales by Type (2013-2017)
6.3.2 Europe Molecular Biomarkers Revenue by Type (2013-2017)
6.4 Europe Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Molecular Biomarkers Market Status by Countries
7.1.1 Asia Pacific Molecular Biomarkers Sales by Countries (2013-2017)
7.1.2 Asia Pacific Molecular Biomarkers Revenue by Countries (2013-2017)
7.1.3 China Molecular Biomarkers Market Status (2013-2017)
7.1.4 Japan Molecular Biomarkers Market Status (2013-2017)
7.1.5 India Molecular Biomarkers Market Status (2013-2017)
7.1.6 Southeast Asia Molecular Biomarkers Market Status (2013-2017)
7.1.7 Australia Molecular Biomarkers Market Status (2013-2017)
7.2 Asia Pacific Molecular Biomarkers Market Status by Manufacturers
7.3 Asia Pacific Molecular Biomarkers Market Status by Type (2013-2017)
7.3.1 Asia Pacific Molecular Biomarkers Sales by Type (2013-2017)
7.3.2 Asia Pacific Molecular Biomarkers Revenue by Type (2013-2017)
7.4 Asia Pacific Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Molecular Biomarkers Market Status by Countries
8.1.1 Latin America Molecular Biomarkers Sales by Countries (2013-2017)
8.1.2 Latin America Molecular Biomarkers Revenue by Countries (2013-2017)
8.1.3 Brazil Molecular Biomarkers Market Status (2013-2017)
8.1.4 Argentina Molecular Biomarkers Market Status (2013-2017)
8.1.5 Colombia Molecular Biomarkers Market Status (2013-2017)
8.2 Latin America Molecular Biomarkers Market Status by Manufacturers
8.3 Latin America Molecular Biomarkers Market Status by Type (2013-2017)
8.3.1 Latin America Molecular Biomarkers Sales by Type (2013-2017)
8.3.2 Latin America Molecular Biomarkers Revenue by Type (2013-2017)
8.4 Latin America Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Molecular Biomarkers Market Status by Countries
9.1.1 Middle East and Africa Molecular Biomarkers Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Molecular Biomarkers Revenue by Countries (2013-2017)
9.1.3 Middle East Molecular Biomarkers Market Status (2013-2017)
9.1.4 Africa Molecular Biomarkers Market Status (2013-2017)
9.2 Middle East and Africa Molecular Biomarkers Market Status by Manufacturers
9.3 Middle East and Africa Molecular Biomarkers Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Molecular Biomarkers Sales by Type (2013-2017)
9.3.2 Middle East and Africa Molecular Biomarkers Revenue by Type (2013-2017)
9.4 Middle East and Africa Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR BIOMARKERS
10.1 Global Economy Situation and Trend Overview
10.2 Molecular Biomarkers Downstream Industry Situation and Trend Overview
CHAPTER 11 MOLECULAR BIOMARKERS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Molecular Biomarkers by Major Manufacturers
11.2 Production Value of Molecular Biomarkers by Major Manufacturers
11.3 Basic Information of Molecular Biomarkers by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Molecular Biomarkers Major Manufacturer
11.3.2 Employees and Revenue Level of Molecular Biomarkers Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MOLECULAR BIOMARKERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Alere
12.1.1 Company profile
12.1.2 Representative Molecular Biomarkers Product
12.1.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Alere
12.2 Atossa Genetics
12.2.1 Company profile
12.2.2 Representative Molecular Biomarkers Product
12.2.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Atossa Genetics
12.3 Biophysical
12.3.1 Company profile
12.3.2 Representative Molecular Biomarkers Product
12.3.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Biophysical
12.4 Abbott
12.4.1 Company profile
12.4.2 Representative Molecular Biomarkers Product
12.4.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Abbott
12.5 BioCept
12.5.1 Company profile
12.5.2 Representative Molecular Biomarkers Product
12.5.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioCept
12.6 BioTheranostics
12.6.1 Company profile
12.6.2 Representative Molecular Biomarkers Product
12.6.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioTheranostics
12.7 DiagnoCure
12.7.1 Company profile
12.7.2 Representative Molecular Biomarkers Product
12.7.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of DiagnoCure
12.8 GenomeDx
12.8.1 Company profile
12.8.2 Representative Molecular Biomarkers Product
12.8.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of GenomeDx
12.9 Genomic Health
12.9.1 Company profile
12.9.2 Representative Molecular Biomarkers Product
12.9.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Genomic Health
12.10 Gen-Probe
12.10.1 Company profile
12.10.2 Representative Molecular Biomarkers Product
12.10.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Gen-Probe
12.11 Life Technologies
12.11.1 Company profile
12.11.2 Representative Molecular Biomarkers Product
12.11.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Life Technologies
12.12 20/20 GeneSystems
12.12.1 Company profile
12.12.2 Representative Molecular Biomarkers Product
12.12.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of 20/20 GeneSystems
12.13 Cynvenio
12.13.1 Company profile
12.13.2 Representative Molecular Biomarkers Product
12.13.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Cynvenio
12.14 Dako (Agilent)
12.14.1 Company profile
12.14.2 Representative Molecular Biomarkers Product
12.14.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Dako (Agilent)
12.15 Epic Sciences
12.15.1 Company profile
12.15.2 Representative Molecular Biomarkers Product
12.15.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Epic Sciences
12.16 Foundation Medicine
12.17 Genomic Health
12.18 Molecular Response
12.19 Nodality
12.20 PGD
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR BIOMARKERS
13.1 Industry Chain of Molecular Biomarkers
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR BIOMARKERS
14.1 Cost Structure Analysis of Molecular Biomarkers
14.2 Raw Materials Cost Analysis of Molecular Biomarkers
14.3 Labor Cost Analysis of Molecular Biomarkers
14.4 Manufacturing Expenses Analysis of Molecular Biomarkers
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Molecular Biomarkers in This Report
1.2 Commercial Types of Molecular Biomarkers
1.2.1 Genomics
1.2.2 Proteomics
1.2.3 Others
1.3 Downstream Application of Molecular Biomarkers
1.3.1 Medicine
1.3.2 Biology
1.3.3 Other
1.4 Development History of Molecular Biomarkers
1.5 Market Status and Trend of Molecular Biomarkers 2013-2023
1.5.1 Global Molecular Biomarkers Market Status and Trend 2013-2023
1.5.2 Regional Molecular Biomarkers Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Molecular Biomarkers 2013-2017
2.2 Sales Market of Molecular Biomarkers by Regions
2.2.1 Sales Volume of Molecular Biomarkers by Regions
2.2.2 Sales Value of Molecular Biomarkers by Regions
2.3 Production Market of Molecular Biomarkers by Regions
2.4 Global Market Forecast of Molecular Biomarkers 2018-2023
2.4.1 Global Market Forecast of Molecular Biomarkers 2018-2023
2.4.2 Market Forecast of Molecular Biomarkers by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Molecular Biomarkers by Types
3.2 Sales Value of Molecular Biomarkers by Types
3.3 Market Forecast of Molecular Biomarkers by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Molecular Biomarkers by Downstream Industry
4.2 Global Market Forecast of Molecular Biomarkers by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Molecular Biomarkers Market Status by Countries
5.1.1 North America Molecular Biomarkers Sales by Countries (2013-2017)
5.1.2 North America Molecular Biomarkers Revenue by Countries (2013-2017)
5.1.3 United States Molecular Biomarkers Market Status (2013-2017)
5.1.4 Canada Molecular Biomarkers Market Status (2013-2017)
5.1.5 Mexico Molecular Biomarkers Market Status (2013-2017)
5.2 North America Molecular Biomarkers Market Status by Manufacturers
5.3 North America Molecular Biomarkers Market Status by Type (2013-2017)
5.3.1 North America Molecular Biomarkers Sales by Type (2013-2017)
5.3.2 North America Molecular Biomarkers Revenue by Type (2013-2017)
5.4 North America Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Molecular Biomarkers Market Status by Countries
6.1.1 Europe Molecular Biomarkers Sales by Countries (2013-2017)
6.1.2 Europe Molecular Biomarkers Revenue by Countries (2013-2017)
6.1.3 Germany Molecular Biomarkers Market Status (2013-2017)
6.1.4 UK Molecular Biomarkers Market Status (2013-2017)
6.1.5 France Molecular Biomarkers Market Status (2013-2017)
6.1.6 Italy Molecular Biomarkers Market Status (2013-2017)
6.1.7 Russia Molecular Biomarkers Market Status (2013-2017)
6.1.8 Spain Molecular Biomarkers Market Status (2013-2017)
6.1.9 Benelux Molecular Biomarkers Market Status (2013-2017)
6.2 Europe Molecular Biomarkers Market Status by Manufacturers
6.3 Europe Molecular Biomarkers Market Status by Type (2013-2017)
6.3.1 Europe Molecular Biomarkers Sales by Type (2013-2017)
6.3.2 Europe Molecular Biomarkers Revenue by Type (2013-2017)
6.4 Europe Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Molecular Biomarkers Market Status by Countries
7.1.1 Asia Pacific Molecular Biomarkers Sales by Countries (2013-2017)
7.1.2 Asia Pacific Molecular Biomarkers Revenue by Countries (2013-2017)
7.1.3 China Molecular Biomarkers Market Status (2013-2017)
7.1.4 Japan Molecular Biomarkers Market Status (2013-2017)
7.1.5 India Molecular Biomarkers Market Status (2013-2017)
7.1.6 Southeast Asia Molecular Biomarkers Market Status (2013-2017)
7.1.7 Australia Molecular Biomarkers Market Status (2013-2017)
7.2 Asia Pacific Molecular Biomarkers Market Status by Manufacturers
7.3 Asia Pacific Molecular Biomarkers Market Status by Type (2013-2017)
7.3.1 Asia Pacific Molecular Biomarkers Sales by Type (2013-2017)
7.3.2 Asia Pacific Molecular Biomarkers Revenue by Type (2013-2017)
7.4 Asia Pacific Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Molecular Biomarkers Market Status by Countries
8.1.1 Latin America Molecular Biomarkers Sales by Countries (2013-2017)
8.1.2 Latin America Molecular Biomarkers Revenue by Countries (2013-2017)
8.1.3 Brazil Molecular Biomarkers Market Status (2013-2017)
8.1.4 Argentina Molecular Biomarkers Market Status (2013-2017)
8.1.5 Colombia Molecular Biomarkers Market Status (2013-2017)
8.2 Latin America Molecular Biomarkers Market Status by Manufacturers
8.3 Latin America Molecular Biomarkers Market Status by Type (2013-2017)
8.3.1 Latin America Molecular Biomarkers Sales by Type (2013-2017)
8.3.2 Latin America Molecular Biomarkers Revenue by Type (2013-2017)
8.4 Latin America Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Molecular Biomarkers Market Status by Countries
9.1.1 Middle East and Africa Molecular Biomarkers Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Molecular Biomarkers Revenue by Countries (2013-2017)
9.1.3 Middle East Molecular Biomarkers Market Status (2013-2017)
9.1.4 Africa Molecular Biomarkers Market Status (2013-2017)
9.2 Middle East and Africa Molecular Biomarkers Market Status by Manufacturers
9.3 Middle East and Africa Molecular Biomarkers Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Molecular Biomarkers Sales by Type (2013-2017)
9.3.2 Middle East and Africa Molecular Biomarkers Revenue by Type (2013-2017)
9.4 Middle East and Africa Molecular Biomarkers Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR BIOMARKERS
10.1 Global Economy Situation and Trend Overview
10.2 Molecular Biomarkers Downstream Industry Situation and Trend Overview
CHAPTER 11 MOLECULAR BIOMARKERS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Molecular Biomarkers by Major Manufacturers
11.2 Production Value of Molecular Biomarkers by Major Manufacturers
11.3 Basic Information of Molecular Biomarkers by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Molecular Biomarkers Major Manufacturer
11.3.2 Employees and Revenue Level of Molecular Biomarkers Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MOLECULAR BIOMARKERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Alere
12.1.1 Company profile
12.1.2 Representative Molecular Biomarkers Product
12.1.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Alere
12.2 Atossa Genetics
12.2.1 Company profile
12.2.2 Representative Molecular Biomarkers Product
12.2.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Atossa Genetics
12.3 Biophysical
12.3.1 Company profile
12.3.2 Representative Molecular Biomarkers Product
12.3.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Biophysical
12.4 Abbott
12.4.1 Company profile
12.4.2 Representative Molecular Biomarkers Product
12.4.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Abbott
12.5 BioCept
12.5.1 Company profile
12.5.2 Representative Molecular Biomarkers Product
12.5.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioCept
12.6 BioTheranostics
12.6.1 Company profile
12.6.2 Representative Molecular Biomarkers Product
12.6.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioTheranostics
12.7 DiagnoCure
12.7.1 Company profile
12.7.2 Representative Molecular Biomarkers Product
12.7.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of DiagnoCure
12.8 GenomeDx
12.8.1 Company profile
12.8.2 Representative Molecular Biomarkers Product
12.8.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of GenomeDx
12.9 Genomic Health
12.9.1 Company profile
12.9.2 Representative Molecular Biomarkers Product
12.9.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Genomic Health
12.10 Gen-Probe
12.10.1 Company profile
12.10.2 Representative Molecular Biomarkers Product
12.10.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Gen-Probe
12.11 Life Technologies
12.11.1 Company profile
12.11.2 Representative Molecular Biomarkers Product
12.11.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Life Technologies
12.12 20/20 GeneSystems
12.12.1 Company profile
12.12.2 Representative Molecular Biomarkers Product
12.12.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of 20/20 GeneSystems
12.13 Cynvenio
12.13.1 Company profile
12.13.2 Representative Molecular Biomarkers Product
12.13.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Cynvenio
12.14 Dako (Agilent)
12.14.1 Company profile
12.14.2 Representative Molecular Biomarkers Product
12.14.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Dako (Agilent)
12.15 Epic Sciences
12.15.1 Company profile
12.15.2 Representative Molecular Biomarkers Product
12.15.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Epic Sciences
12.16 Foundation Medicine
12.17 Genomic Health
12.18 Molecular Response
12.19 Nodality
12.20 PGD
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR BIOMARKERS
13.1 Industry Chain of Molecular Biomarkers
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR BIOMARKERS
14.1 Cost Structure Analysis of Molecular Biomarkers
14.2 Raw Materials Cost Analysis of Molecular Biomarkers
14.3 Labor Cost Analysis of Molecular Biomarkers
14.4 Manufacturing Expenses Analysis of Molecular Biomarkers
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
